Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/16/2010 | US7678545 sequentially-depositing layers of cationic and anionic polyelectrolytes at a liquid-liquid interface that is formed between immiscible first and second liquids whereby a polyelectrolyte multilayer film is provided at the liquid-liquid interface |
03/16/2010 | US7678544 ADAM12, a novel marker for abnormal cell function |
03/16/2010 | US7678542 Charge tags and the separation of nucleic acid molecules |
03/16/2010 | US7678540 Biomimetic chemotaxis receptor-signal complex for use in identifying modulators of B-cell and T-cell receptor signaling pathways; immunotherapy |
03/16/2010 | US7678539 Arrays of biological membranes and methods and use thereof |
03/16/2010 | US7678372 Tyrosine kinase inhibitors; anticancer agents; genetic engineered protein |
03/16/2010 | US7678357 Electrical connection structure, production method thereof, and electric wiring method |
03/16/2010 | US7678336 Channel apparatus for focusing a fluid flow |
03/16/2010 | US7678331 Automatic loading of sample tubes for clinical analyzer |
03/16/2010 | US7678328 Rotatable bomb |
03/16/2010 | US7678261 Apparatus and method for measuring reaction result of samples on biosensor |
03/16/2010 | US7678249 Instrument and system for pharmacologic measurement and well vessel used therein |
03/16/2010 | US7678233 Machine direction sensor system with cross direction averaging |
03/16/2010 | US7677082 Solid state gas sensors based on tunnel junction geometry |
03/16/2010 | US7677081 Method for analyzing gas components, apparatus for separating gas components and method for identifying the same |
03/16/2010 | CA2481425C Disposable sensor with enhanced sample port inlet |
03/16/2010 | CA2410626C Methods for separating and detecting specific polyhalogenated diaromatic hydrocarbons |
03/16/2010 | CA2410023C Coated nanoparticles |
03/16/2010 | CA2407156C Method of evaluating logs to predict properties of lumber or veneer produced from the logs |
03/16/2010 | CA2397495C Composition for detecting beta-1,3-glucan, preparation method thereof and diagnostic kit detecting beta-1,3-glucan |
03/16/2010 | CA2345376C Water-soluble luminescent quantum dots and bioconjugates thereof |
03/16/2010 | CA2327311C Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
03/16/2010 | CA2302838C Modulation of the sphingosine kinase signalling pathway |
03/16/2010 | CA2296766C Aggrecan degrading metallo proteases |
03/16/2010 | CA2287129C Stabilization of biological fluids by addition of sterol esters |
03/16/2010 | CA2142867C Biotinylated chemiluminescent labels, conjugates, assays, assay kits |
03/14/2010 | CA2678327A1 Method for determining reheat cracking susceptibility |
03/11/2010 | WO2010028388A1 Methods and compositions for direct detection of dna damage |
03/11/2010 | WO2010028373A2 Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients |
03/11/2010 | WO2010028372A2 Methods and kits for the diagnosis of ryr1-related diseases |
03/11/2010 | WO2010028336A2 Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status |
03/11/2010 | WO2010028288A2 Methods for stratifying and annotating cancer drug treatment options |
03/11/2010 | WO2010028277A1 Pan-kinase activation and evaluation of signaling pathways |
03/11/2010 | WO2010028274A1 Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation |
03/11/2010 | WO2010028264A1 Methods and compositions for identifying modulators of anti-tetherin activity to inhibit propagation of viruses |
03/11/2010 | WO2010028248A1 Biomarkers, kits, and method for diagnosing, monitoring, and/or staging alzheimer's disease |
03/11/2010 | WO2010028214A2 Screening method to identify molecules having the ability to modulate the activity of a catalyst |
03/11/2010 | WO2010028160A1 Methods for the detection of circulating tumor cells |
03/11/2010 | WO2010028072A2 Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use |
03/11/2010 | WO2010028014A1 Assays and kits for determining hiv-1 tropism |
03/11/2010 | WO2010028013A2 In vivo biofilm infection diagnosis and treatment |
03/11/2010 | WO2010027995A1 Hydrolysis-resistant polyacrylamide gels |
03/11/2010 | WO2010027903A2 Lung cancer diagnosis |
03/11/2010 | WO2010027877A2 Small molecule fluorescent sensors for detection of post-translational modifications and protein-protein interactions in bioassays |
03/11/2010 | WO2010027818A2 Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use |
03/11/2010 | WO2010027812A2 Microfluidic systems incorporating flow-through membranes |
03/11/2010 | WO2010027785A2 Measurement of biological targets |
03/11/2010 | WO2010027771A1 Analyte sensor |
03/11/2010 | WO2010027745A2 Pentraxin-3 as a biomarker for metabolic syndrome and in assessing coronary risk |
03/11/2010 | WO2010027729A2 Gonococcal vaccines |
03/11/2010 | WO2010027675A1 Collapsible lancing device |
03/11/2010 | WO2010027668A1 Sensor for detecting and differentiating chemical analytes |
03/11/2010 | WO2010027642A2 Selecting for cooperatively interacting molecules |
03/11/2010 | WO2010027590A2 Solution microarrays and uses thereof |
03/11/2010 | WO2010027514A2 Coated sensors and methods related thereto |
03/11/2010 | WO2010027499A2 Methods, compositions and vaccines relating to neisseria meningitidis antibodies |
03/11/2010 | WO2010027446A2 Synaptic vesicle cycling assays and systems |
03/11/2010 | WO2010027267A1 Method and apparatus for measuring metal portion in dross |
03/11/2010 | WO2010027260A2 Biomarkers for identifying subjects predisposed to developing insulin resistance and determining the insulin resistance status |
03/11/2010 | WO2010027108A1 Fluorescent sugar derivative compound and sensor using same |
03/11/2010 | WO2010027012A1 Tissue piece forming device and tissue piece forming method |
03/11/2010 | WO2010027003A1 Cell detection method, and microarray chip for use in the method |
03/11/2010 | WO2010026965A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
03/11/2010 | WO2010026950A1 Dna detection apparatus, dna detection device and dna detection method |
03/11/2010 | WO2010026913A1 Sample collecting implement |
03/11/2010 | WO2010026911A1 Sample collecting device and containing container used for same |
03/11/2010 | WO2010026758A1 Monoclonal antibody, and immunoassay using same |
03/11/2010 | WO2010026573A1 Methods of selection of cells for transplantation |
03/11/2010 | WO2010026551A1 Rotating magnetic field for improved detection in cluster assays |
03/11/2010 | WO2010026489A1 Innate immunity modulators |
03/11/2010 | WO2010026473A2 Pta072 protein |
03/11/2010 | WO2010026358A1 Device and method for optically measuring the transmission and diffusion of ocular media |
03/11/2010 | WO2010026346A1 Stable cell clone expressing a prion |
03/11/2010 | WO2010026281A1 Determining the amount of starch |
03/11/2010 | WO2010026275A1 Biosensor for detecting anti-hiv antibodies |
03/11/2010 | WO2010026272A1 Methods and compositions for the treatment and diagnosis of haemorrhagic conversion |
03/11/2010 | WO2010026225A1 New method of imaging by mass spectrometry and new mass tag associated trityl derivatives |
03/11/2010 | WO2010026218A1 Method for testing substances or substance mixtures and the use thereof |
03/11/2010 | WO2010026165A1 Novel melanoma antigen peptide and uses thereof |
03/11/2010 | WO2010025928A1 Method for prediction of the progression risk of tumors |
03/11/2010 | WO2010025915A1 Screening methods for transfusion related acute lung injury (trali) |
03/11/2010 | WO2010025756A1 Reaction vessel capable of detecting carrier-bound analyte complexes, method for detecting carrier-bound analyte complexes, and kit of parts |
03/11/2010 | WO2010025745A1 Method for capturing measurement values and displaying measurement values |
03/11/2010 | WO2010025719A1 Biopsy instrument for enriching sample material |
03/11/2010 | WO2010025715A2 Method for precisely determining the fluorescence in a layer system, such as the eye |
03/11/2010 | WO2010025548A1 Sperm fertility biomarkers and uses thereof |
03/11/2010 | WO2010025547A1 Nanostructured microelectrodes and biosensing devices incorporating the same |
03/11/2010 | WO2010009000A3 Strip connectors for measurement devices |
03/11/2010 | WO2010008736A3 Cancer diagnosis based on levels of antibodies against globo h and its fragments |
03/11/2010 | WO2010007615A9 Piezoelectrical characterization of materials |
03/11/2010 | WO2010007532A3 Automatic information transfer by color encoded fields |
03/11/2010 | WO2010007175A3 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
03/11/2010 | WO2010004438A3 Lm-antibodies, functional fragments, lm-1 target antigen, and methods for making and using same |
03/11/2010 | WO2010004177A3 Method for preventing a vehicle engine from running |
03/11/2010 | WO2010002955A3 Stemness signature biomarkers and methods of use |
03/11/2010 | WO2010002890A3 Methods of promoting weight loss and associated arrays |
03/11/2010 | WO2010002123A3 Medical urinal for autodiagnosis |
03/11/2010 | WO2010000467A8 Asc as a marker for lung cancer |
03/11/2010 | WO2009158529A8 Lyophilization cycle robustness strategy |
03/11/2010 | WO2009155283A3 Radiolabled cyclopamine assay for the smoothened receptor |